Significance of MDR1 gene polymorphism C3435T in predicting drug response in epilepsy. 2014

Uzma Shaheen, and D K V Prasad, and Vandana Sharma, and T Suryaprabha, and Y R Ahuja, and A Jyothy, and Anjana Munshi
Institute of Genetics and Hospital for Genetic Diseases, OU, Begumpet 500016, India; Dr NTR University of Health Sciences, Vijayawada, India.

Antiepileptic drug (AED) treatment in epilepsy is often compromised by the unpredictability of efficacy and inter-individual variability among patients, which at least in part is the result of genetic variation. The idea to determine an individual's response to a prescribed medicine came into inception around 29 years ago. Pharmacogenetics is used to predict the drug response and efficacy, as well as potential adverse effects. We investigated the functional significance of the C3435T polymorphism of the MDR1 gene in a South Indian population. The patients were divided into responders and non-responders based on their clinical outcome and AED response. The risk of drug resistance was significantly higher in patients bearing TT genotype in comparison to carriers of the homozygous CC genotype [TT vs. CC, χ(2)=12.52; p=0.001, Odds ratio=2.34 (95% CI: 1.942-11.32)]. We suggest that the influence of the C3435T polymorphism in predicting the drug-resistance in epilepsy, might be significant and further investigations focusing on carbamazepine and phenytoin, in various ethnic populations are necessary to clarify the effect of C3435T polymorphism on the multidrug resistance in epilepsy patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Uzma Shaheen, and D K V Prasad, and Vandana Sharma, and T Suryaprabha, and Y R Ahuja, and A Jyothy, and Anjana Munshi
May 2017, Epilepsy research,
Uzma Shaheen, and D K V Prasad, and Vandana Sharma, and T Suryaprabha, and Y R Ahuja, and A Jyothy, and Anjana Munshi
January 2015, Seizure,
Uzma Shaheen, and D K V Prasad, and Vandana Sharma, and T Suryaprabha, and Y R Ahuja, and A Jyothy, and Anjana Munshi
March 2017, Acta neurologica Belgica,
Uzma Shaheen, and D K V Prasad, and Vandana Sharma, and T Suryaprabha, and Y R Ahuja, and A Jyothy, and Anjana Munshi
July 2014, Journal of neural transmission (Vienna, Austria : 1996),
Uzma Shaheen, and D K V Prasad, and Vandana Sharma, and T Suryaprabha, and Y R Ahuja, and A Jyothy, and Anjana Munshi
October 2013, Clinica chimica acta; international journal of clinical chemistry,
Uzma Shaheen, and D K V Prasad, and Vandana Sharma, and T Suryaprabha, and Y R Ahuja, and A Jyothy, and Anjana Munshi
January 2018, Microbial pathogenesis,
Uzma Shaheen, and D K V Prasad, and Vandana Sharma, and T Suryaprabha, and Y R Ahuja, and A Jyothy, and Anjana Munshi
August 2001, Lancet (London, England),
Uzma Shaheen, and D K V Prasad, and Vandana Sharma, and T Suryaprabha, and Y R Ahuja, and A Jyothy, and Anjana Munshi
February 2007, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
Uzma Shaheen, and D K V Prasad, and Vandana Sharma, and T Suryaprabha, and Y R Ahuja, and A Jyothy, and Anjana Munshi
July 2016, Behavioral and brain functions : BBF,
Uzma Shaheen, and D K V Prasad, and Vandana Sharma, and T Suryaprabha, and Y R Ahuja, and A Jyothy, and Anjana Munshi
September 2008, Molecular biology reports,
Copied contents to your clipboard!